• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday

    9/16/22 4:38:59 AM ET
    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADBE alert in real time by email

    Gainers

    • HeartBeam, Inc. (NASDAQ:BEAT) shares jumped 85.6% to close at $2.32 on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 47.2% to close at $24.82 after the company announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo.
    • Nabriva Therapeutics plc (NASDAQ:NBRV) climbed 39.4% to close at $0.2671 after the company announced it will effect a 1-for-25 reverse stock split of its outstanding ordinary shares, which will be effective on September 16, 2022.
    • ZW Data Action Technologies Inc. (NASDAQ:CNET) gained 37.4% to close at $0.91. ZW Data Action Technologies reported planned acquisition of Henan Baodun.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) gained 32.7% to close at $7.76.
    • Secoo Holding Limited (NASDAQ:SECO) gained 27.3% to close at $0.3309 after Aladdin Technology Group agreed to invest RMB1.3 million in the company.
    • Getty Images Holdings, Inc. (NYSE:GETY) rose 25.7% to settle at $13.35.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 25.7% to close at $3.57.
    • ATIF Holdings Limited (NASDAQ:ATIF) surged 23.6% to close at $1.99.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 20.1% to close at $1.2250.
    • Republic First Bancorp, Inc. (NASDAQ:FRBK) jumped 20.1% to settle at $3.11 as the company announced a strategic review; in light of inquiries by multiple parties expressing interest in one or more potential strategic transactions with the company.
    • STORE Capital Corporation (NYSE:STOR) gained 19.9% to close at $32.12 after the company announced it will be acquired by GIC and Oak Street in a $14 billion transaction.
    • Better Choice Company Inc. (NYSE:BTTR) climbed 19.2% to settle at $1.68.
    • SAB Biotherapeutics, Inc. (NASDAQ:SABS) rose 17.9% to close at $0.8256. SAB Biotherapeutics, Inc. (NASDAQ:SABS) Director Christine Hamilton acquired a total of 10,000 shares at an average price of $0.73.
    • Jowell Global Ltd. (NASDAQ:JWEL) surged 17.9% to settle at $2.37.
    • Augmedix, Inc. (NASDAQ:AUGX) gained 16.3% to close at $2.35.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) jumped 15.4% to settle at $3.15.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) rose 14.7% to close at $0.2368.
    • Porch Group, Inc. (NASDAQ:PRCH) jumped 14.6% to close at $2.90.
    • Enochian Biosciences, Inc. (NASDAQ:ENOB) gained 13.9% to close at $2.80 after declining around 6% on Wednesday.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 13.2% to close at $0.86.
    • Addentax Group Corp. (NASDAQ:ATXG) shares gained 13% to close at $5.40 after jumping 17% on Wednesday.
    • Champions Oncology, Inc. (NASDAQ:CSBR) jumped 12.5% to settle at $8.75. Champions Oncology recently posted a Q1 loss of $0.02 per share.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 12% to close at $1.06.
    • Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) gained 12% to close at $0.28.
    • Eve Holding, Inc. (NYSE:EVEX) jumped 10.6% to settle at $10.63. United recently announced a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
    • EVgo, Inc. (NASDAQ:EVGO) gained 9.2% to close at $10.14. EVgo launched Connect the Watts National EV Charging Recognition Program.
    • Humana Inc. (NYSE:HUM) climbed 8.4% to close at $497.24 after the company raised FY22 adjusted EPS guidance above estimates. The company also issued FY25 adjusted EPS guidance of $37 per share.
    • Roku, Inc. (NASDAQ:ROKU) gained 8% to close at $73.81.
    • Canoo Inc. (NASDAQ:GOEV) gained 7.7% to close at $2.80. Canoo Chairman, CEO Tony Aquila disclosed the purchase of 200k shares of the company’s common stock at an average price of $2.58 per share.
    • Wynn Resorts, Limited (NASDAQ:WYNN) gained 7.5% to close at $65.23. Credit Suisse upgraded Wynn Resorts from Neutral to Outperform.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) rose 6.5% to close at $0.9457.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares gained 5.6% to close at $0.2270. Sonnet BioTherapeutics, last month, posted a Q3 loss of $0.13 per share.
    • Ra Medical Systems, Inc. (NASDAQ:RMED) gained 5.5% to close at $0.1688. Ra Medical Systems recently announced a reverse merger agreement with Catheter Precision.

     


    Losers

    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) dropped 55.7% to close at $16.63 on Thursday. Shuttle Pharmaceuticals was awarded new HDAC inhibitor patents for cancer treatment.
    • IronNet, Inc. (NASDAQ:IRNT) shares fell 44.6% to close at $1.22 after the company reported worse-than-expected Q2 EPS and sales results. The company also withdrew its FY23 guidance in light of management transitions, restructuring and underperformance of current quarter.
    • Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) dipped 41% to close at $0.2243 after the company announced the combination of subcutaneous ELX-02 with ivacaftor did not achieve statistical significance for efficacy endpoints in Phase 2 study in Class 1 cystic fibrosis.
    • Color Star Technology Co., Ltd. (NASDAQ:CSCW) dropped 39.6% to close at $0.0713 after the company announced a $5.6 million registered direct offering priced at $0.08 per unit.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) declined 37.8% to close at $2.11 amid circulation of a post on GiveSendGo from a patient in the TCR-T Library Phase 1/2 Trial.
    • AMTD Digital Inc. (NYSE:HKD) shares fell 28.9% to close at $134.69 after jumping 312% on Wednesday.
    • Omeros Corporation (NASDAQ:OMER) fell 26% to close at $3.99 after the company reported Narsoplimab treatment results in critically ill COVID-19 patients in I-SPY COVID trial.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares fell 25% to close at $0.2670 after gaining around 53% on Wednesday.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) shares fell 24.4% to close at $23.31. Rhythm Pharmaceuticals priced its 4.8 million share public offering of common stock at $26 per share.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 22.6% to close at $0.3250 after the company reported a proposed public offering of common stock and warrants.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) declined 19.4% to close at $2.04 after dropping 12% on Wednesday.
    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) fell 18.6% to close at $5.90. Ventoux CCM Acquisition stockholders approved proposed business combination with Presto.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) declined 18.5% to close at $0.8480.
    • Adobe Inc. (NASDAQ:ADBE) dropped 16.8% to close at $309.13 after the company reported Q3 earnings results, issued Q4 sales guidance below estimates and announced it will acquire Figma for approximately $20 billion in cash and stock.
    • Arconic Corp (NYSE:ARNC) fell 16.6% to close at $21.24 as the company lowered its FY22 sales outlook from $9.6 billion-$10 billion to $9.2 billion-$9.5 billion. The company also said it sees Q3 Adjusted EBITDA to be in the range of $135 million to $150 million.
    • Aerovate Therapeutics, Inc. (NASDAQ:AVTE) dropped 16.5% to close at $15.84.
    • CF Acquisition Corp. VI (NASDAQ:CFVI) fell 16.3% to settle at $11.62.
    • Spectrum Brands Holdings, Inc. (NYSE:SPB) dropped 16.2% to close at $49.29. Spectrum Brands' will oppose attempt to block the U.S. Department of Justice's Opposition to the sale of its Hardware and Home Improvement division to ASSA ABLOY.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) fell 16.2% to settle at $1.29. LightPath Technologies recently reported worse-than-expected Q4 results.
    • Minerva Surgical, Inc. (NASDAQ:UTRS) dipped 15.7% to close at $1.18.
    • Akerna Corp. (NASDAQ:KERN) fell 15.5% to settle at $0.1394.
    • SciSparc Ltd. (NASDAQ:SPRC) declined 15.1% to close at $0.8189. SciSparc announced it entered into an agreement to acquire Wellution for $20 million.
    • Concord Medical Services Holdings Limited (NYSE:CCM) dipped 15% to settle at $1.70.
    • Yoshiharu Global Co. (NASDAQ:YOSH) declined 13.8% to close at $2.12.
    • FTC Solar, Inc. (NASDAQ:FTCI) fell 13.3% to settle at $3.77. FTC Solar and Primoris announced 500 megawatt tracker supply agreement.
    • Mondee Holdings, Inc. (NASDAQ:MOND) fell 13% to settle at $12.00.
    • Edgewise Therapeutics, Inc. (NASDAQ:EWTX) dipped 12.8% to close at $9.13.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) dropped 12.6% to settle at $9.61.
    • Steelcase Inc. (NYSE:SCS) fell 10.9% to close at $9.60. Sidoti & Co. downgraded Steelcase from Buy to Neutral.
    • Groupon, Inc. (NASDAQ:GRPN) fell 10.8% to close at $11.13 after the company said Q3 adjusted EBITDA is expected to be lower than Q2.
    • Array Technologies, Inc. (NASDAQ:ARRY) fell 9.5% to close at $18.01. MuddyWatersResearch discussed short report on Zer0es.tv.
    • CVR Energy, Inc. (NYSE:CVI) fell 9.5% to settle at $29.63. Wolfe Research downgraded CVR Energy from Outperform to Peer Perform.
    • Aditxt, Inc. (NASDAQ:ADTX) fell 9.1% to close at $10.39. Aditxt announced a 1-for-50 reverse stock split effective on September 14, 2022.
    • Wearable Devices Ltd. (NASDAQ:WLDS) fell 7.8% to close at $2.72 on post-IPO volatility after the stock opened for trade on Tuesday.
    • The Oncology Institute, Inc. (NASDAQ:TOI) dropped 7.6% to close at $4.61.
    • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 6% to close at $11.76. IDEAYA priced its 7.62 million share public offering of common stock at $10.50 per share.
    • PBF Energy Inc. (NYSE:PBF) fell 5.5% to close at $28.77. Shares of oil companies traded lower after rail companies and union negotiators came to a tentative agreement, averting a railroad strike. A strike would have caused supply shortages and lifted oil prices.
    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ADTX
    $ARNC
    $ARRY

    CompanyDatePrice TargetRatingAnalyst
    Porch Group Inc.
    $PRCH
    2/11/2026$10.50Mkt Perform → Outperform
    Keefe Bruyette
    Roku Inc.
    $ROKU
    2/6/2026$105.00Perform → Outperform
    Oppenheimer
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    LightPath Technologies Inc.
    $LPTH
    1/29/2026$15.00Buy
    Canaccord Genuity
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Adobe Inc.
    $ADBE
    1/13/2026Outperform → Perform
    Oppenheimer
    Adobe Inc.
    $ADBE
    1/12/2026$290.00Sell
    Goldman
    More analyst ratings

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Porch Group upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Porch Group from Mkt Perform to Outperform and set a new price target of $10.50

    2/11/26 7:42:24 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Roku upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Roku from Perform to Outperform and set a new price target of $105.00

    2/6/26 8:05:48 AM ET
    $ROKU
    Cable & Other Pay Television Services
    Telecommunications

    Adobe downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Adobe from Overweight to Neutral and set a new price target of $330.00

    2/3/26 6:51:31 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Control Empresarial De Capitales S.A. De C.V. sold $8,105,713 worth of Class A Common Shares (229,900 units at $35.26) (SEC Form 4)

    4 - PBF Energy Inc. (0001534504) (Issuer)

    2/11/26 9:06:01 PM ET
    $PBF
    Integrated oil Companies
    Energy

    SEC Form 4 filed by Large owner Fertitta Tilman J

    4 - WYNN RESORTS LTD (0001174922) (Issuer)

    2/11/26 4:30:13 PM ET
    $WYNN
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 4 filed by Large owner Fertitta Tilman J

    4 - WYNN RESORTS LTD (0001174922) (Issuer)

    2/9/26 4:30:26 PM ET
    $WYNN
    Hotels/Resorts
    Consumer Discretionary

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PBF Energy Reports Fourth Quarter and Full Year 2025 Results, Declares Dividend of $0.275 per Share

    Fourth quarter income from operations of $128.0 million (excluding special items, fourth quarter income from operations of $99.4 million)Full year loss from operations of $54.3 million (excluding special items, full year loss from operations of $479.5 million)Declares quarterly dividend of $0.275 per shareMartinez refinery restart on schedulePARSIPPANY, N.J., Feb. 12, 2026 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today reported fourth quarter 2025 income from operations of $128.0 million as compared to loss from operations of $383.2 million for the fourth quarter of 2024. Excluding special items, fourth quarter 2025 income from operations was $99.4 million as compared to loss from operatio

    2/12/26 6:30:00 AM ET
    $PBF
    Integrated oil Companies
    Energy

    Xilio Therapeutics Announces Pricing of Underwritten Offering

    WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the pricing of an underwritten offering of pre-funded warrants to purchase 74,780,300 shares of common stock at a price to investors of $0.5349 per pre-funded warrant (the "pre-funded warrants"). Each pre-funded warrant is exercisable for one share of common stock at an exercise price of $0.0001 per share. The pre-funded warrants will be exercisable immediately and will be exercisable until all of the pre-funded warrants are exercised in full. The offering is

    2/11/26 9:34:13 PM ET
    $XLO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LightPath Technologies Reports Fiscal 2026 Second Quarter Financial Results

    ORLANDO, Fla., Feb. 11, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal second quarter ended December 31, 2025.   Financial Summary: Three Months Ended December 31, $ in millions 2025 2024 % Change Revenue $16.4 $7.4 120 % Gross Profit $6.0 $1.9 212 % Operating Expenses* $14.6 $4.4 231 % Net Loss ($9.4) ($2.6) 260 % Adjusted EBITDA** $0.6 ($1.3) 144 % * Inc

    2/11/26 4:05:00 PM ET
    $LPTH
    Semiconductors
    Technology

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carroll Anthony bought $101,380 worth of shares (10,638 units at $9.53), increasing direct ownership by 78% to 24,205 units (SEC Form 4)

    4 - FTC Solar, Inc. (0001828161) (Issuer)

    12/18/25 8:00:03 AM ET
    $FTCI
    Semiconductors
    Technology

    Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/24/25 5:08:13 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exec VP Finance, CFO Rosenblum Mark J bought $16,000 worth of shares (20,000 units at $0.80), increasing direct ownership by 11,299% to 20,177 units (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/20/25 4:42:09 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    SEC Filings

    View All

    SEC Form 10-K filed by PBF Energy Inc.

    10-K - PBF Energy Inc. (0001534504) (Filer)

    2/12/26 7:06:47 AM ET
    $PBF
    Integrated oil Companies
    Energy

    InMed Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)

    2/11/26 8:51:22 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by PBF Energy Inc.

    SCHEDULE 13D/A - PBF Energy Inc. (0001534504) (Subject)

    2/11/26 8:52:03 PM ET
    $PBF
    Integrated oil Companies
    Energy

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Financials

    Live finance-specific insights

    View All

    PBF Energy Reports Fourth Quarter and Full Year 2025 Results, Declares Dividend of $0.275 per Share

    Fourth quarter income from operations of $128.0 million (excluding special items, fourth quarter income from operations of $99.4 million)Full year loss from operations of $54.3 million (excluding special items, full year loss from operations of $479.5 million)Declares quarterly dividend of $0.275 per shareMartinez refinery restart on schedulePARSIPPANY, N.J., Feb. 12, 2026 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today reported fourth quarter 2025 income from operations of $128.0 million as compared to loss from operations of $383.2 million for the fourth quarter of 2024. Excluding special items, fourth quarter 2025 income from operations was $99.4 million as compared to loss from operatio

    2/12/26 6:30:00 AM ET
    $PBF
    Integrated oil Companies
    Energy

    Porch Group Reports Fourth Quarter 2025 Results

    Strong Q4 Performance Caps Off a Successful First Year Under Reciprocal Model Porch Group, Inc. ("Porch," "the Company," "we," "our," "us") (NASDAQ:PRCH), a new kind of homeowners insurance company, today reported fourth quarter and full-year results through December 31, 2025, that exceeded our expectations. Porch generated for shareholders1 fourth quarter 2025 revenue of $112.3 million. Net loss attributable to Porch was $(3.5) million, and Adjusted EBITDA was $23.5 million. In January 2025, the Porch Reciprocal Exchange ("Reciprocal") was formed as an insurance entity owned by its policyholder-members and not by Porch. While Porch does not own the Reciprocal, it is consolidated for

    2/11/26 4:02:00 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Leadership Updates

    Live Leadership Updates

    View All

    HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

    Brings more than 25 years of experience in building and scaling groundbreaking cardiovascular technologies Will initially focus on launching the Company's FDA-cleared 12-lead ECG system for arrhythmia assessment Will lead the Company's broader commercialization strategy across key growth initiatives, including heart attack detection and the 12-lead ECG extended-wear patch HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the appointment of Bryan Humbarger as Chief Commercial Officer, effective January 22, 2026. In this newly created role, Mr. Humbarger will lead commercial strate

    1/22/26 7:00:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    LightPath Technologies Acquires Amorphous Materials, Inc.

    Strategic Purchase to Add Proprietary Large Diameter Glass Melting Technology of Chalcogenide Glass ORLANDO, Fla., Jan. 20, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced it has acquired the assets of Amorphous Materials, Inc., ("AMI") an industrial manufacturer with complementary Chalcogenide glass melting technologies, in particular for large diameter optics, purchased for aggregate consideration of $7.0 million in cash, with the potential for up to $3 million of additional technical milestone-based equ

    1/20/26 4:59:00 PM ET
    $LPTH
    Semiconductors
    Technology

    FTC Solar Appoints Wes Fuller VP, North America Utility Sales

    AUSTIN, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (NASDAQ:FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has named Wes Fuller as its Vice President of North America Utility Sales. Fuller will report to Kent James, Chief Commercial Officer for North America. "Wes has an extensive track record of commercial leadership across the renewables industry, including trackers and energy storage," said Kent James. "His expertise, leadership and deep industry relationships will be instrumental in expanding our reach and delivering innovative tracker solutions to our customers." "I am thrilled to join FTC Solar at such a

    1/13/26 8:02:00 AM ET
    $FTCI
    Semiconductors
    Technology

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by CVR Energy Inc.

    SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

    1/7/25 6:12:47 AM ET
    $CVI
    Integrated oil Companies
    Energy

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $ADBE
    $ADTX
    $ARNC
    $ARRY
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care